This map shows the geographic impact of S. Fracchioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Fracchioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Fracchioli more than expected).
This network shows the impact of papers produced by S. Fracchioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Fracchioli. The network helps show where S. Fracchioli may publish in the future.
Co-authorship network of co-authors of S. Fracchioli
This figure shows the co-authorship network connecting the top 25 collaborators of S. Fracchioli.
A scholar is included among the top collaborators of S. Fracchioli based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S. Fracchioli. S. Fracchioli is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Wiley, Andrew, S. Fracchioli, Dionyssios Katsaros, & Herbert Yu. (2004). Methylation of the IGFBP-3 gene and prognosis of epithelial ovarian cancer. Cancer Research. 64. 241–241.1 indexed citations
Luo, Liu‐Ying, Dionyssios Katsaros, Andreas Scorilas, et al.. (2003). The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.. PubMed. 63(4). 807–11.131 indexed citations
Zhang, Lin, Nuo Yang, José R. Conejo-García, et al.. (2003). Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.. PubMed. 9(1). 264–72.52 indexed citations
12.
Borgoño, Carla A., Linda Grass, Antoninus Soosaipillai, et al.. (2003). Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.. PubMed. 63(24). 9032–41.99 indexed citations
13.
Zhang, Lin, Nuo Yang, Jin-Wan Park, et al.. (2003). Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.. PubMed. 63(12). 3403–12.224 indexed citations
Luo, Liu‐Ying, Dionyssios Katsaros, Andreas Scorilas, et al.. (2001). Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.. PubMed. 7(8). 2372–9.93 indexed citations
Obiezu, Christina V., Andreas Scorilas, D Katsaros, et al.. (2001). Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.. PubMed. 7(8). 2380–6.108 indexed citations
19.
Katsaros, Dionyssios, Franco Tarro Genta, Hong Yu, et al.. (2000). Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.. PubMed. 6(8). 3260–70.25 indexed citations
20.
Katsaros, Dionyssios, S. Fracchioli, Henriëtte J.G. Arts, et al.. (1999). [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].. PubMed. 51(12). 463–70.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.